Stilnoct vs. Flexeril: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Stilnoct and Flexeril. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 275,174 people who take Stilnoct and Flexeril, and is updated regularly.
What is Stilnoct?
Stilnoct has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 468 Stilnoct users. Check the latest studies of Stilnoct.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
275,174 people who take Stilnoct and Flexeril are studied.
Drugs being compared in this study:
- Stilnoct (zolpidem tartrate)
- Flexeril (cyclobenzaprine hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Stilnoct:
- not at all: 2.06 %
- somewhat: 16.19 %
- moderate: 31.98 %
- high: 34.22 %
- very high: 15.54 %
Flexeril:
- not at all: 3.85 %
- somewhat: 29.29 %
- moderate: 36.84 %
- high: 23.45 %
- very high: 6.5600000000000005 %
Want to compare Stilnoct with Flexeril?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Stilnoct:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on zolpidem tartrate and cyclobenzaprine hydrochloride (the active ingredients of Stilnoct and Flexeril, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lasix cause Mean Cell Volume Increased? - 2 seconds ago
- Deep Venous Thrombosis and Bronchitis - 5 seconds ago
- Could Liothyronine Sodium cause Nosebleed? - 6 seconds ago
- Drug interactions of Valerian and Tamsulosin - 13 seconds ago
- Drug interactions of Naratriptan and Oxycodone - 13 seconds ago
- Sleep Disorder and Breast Pain - 20 seconds ago
- Could Galantamine Hydrobromide cause Eating Disorder? - 32 seconds ago
- Could Euthyrox cause Paronychia? - 38 seconds ago
- Could Prolia cause Mobility Decreased? - 39 seconds ago
- Drug interactions of Vitamin B12 and Insulin - 45 seconds ago